Download FREE Sample
Buy Now
List of Top Healthcare Analytical Testing Services Market Companies
- Eurofins Scientific
- Labcorp
- SGS
- Charles River
- Wuxi Pharmatech
- Pharmaceutical Product Development
- LLC (PPD)
- Exova
- Pace Analytical
- Envigo
- Intertek
- MPI Research
- Merck KGaA
- Source Bioscience
Top Two companies with highest Marketshare
- Eurofins Scientific: Eurofins Scientific leads the global Healthcare Analytical Testing Services Market with approximately 12.8 % market share in 2024, operating more than 900 laboratories in over 60 countries. The company completed over 450 000 analytical testing projects for pharmaceuticals and biopharmaceuticals worldwide during 2024.
- Labcorp: Labcorp holds the second-largest share of the Healthcare Analytical Testing Services Market at about 10.2 % in 2024. It processed more than 35 million clinical and pharmaceutical analytical tests annually and operates 12 central testing facilities globally.
Investment Analysis and Opportunities
The Healthcare Analytical Testing Services Market is experiencing strong investment inflows from both public and private sectors. Between 2022 and 2024, total capital investment in laboratory infrastructure grew by 18 %, with over USD 3.2 billion equivalent directed toward advanced bioanalytical, stability, and microbial testing capabilities. Approximately 42 % of analytical service providers expanded laboratory footprints or formed new collaborations with pharmaceutical clients to meet outsourcing demand.
Asia-Pacific attracted 27 % of total global analytical investment in 2024 due to cost-effective infrastructure and clinical trial expansion in India and China. In North America, one in three contract research organizations (CROs) launched dedicated analytical testing divisions by 2024, highlighting the market’s capacity expansion. The growing trend toward personalized medicine and biologics, which account for over 55 % of new drug submissions, continues to create lucrative opportunities for analytical testing investments across stability, impurity, and bioassay service domains.
New Product Development
Innovation within the Healthcare Analytical Testing Services Market has intensified between 2023 and 2025, driven by digital transformation, automation, and high-throughput testing technologies. More than 65 % of top analytical laboratories introduced automated sample-tracking and data-integrity platforms in 2024. The adoption of high-resolution mass spectrometry (HRMS) and ultra-performance liquid chromatography (UPLC) systems increased by 34 % during 2023–2024, enhancing accuracy and throughput.
Laboratories integrated AI-driven predictive analytics for impurity profiling and stability forecasting, improving result reproducibility by 20 %. Innovations in extractables and leachables testing expanded to cover 30 % more materials and packaging types than in 2022. Companies such as Eurofins, Labcorp, and SGS also introduced end-to-end digital reporting tools that reduced data-processing time by 40 %. These developments mark a significant shift toward real-time, automated, and data-secure analytical testing, aligning with stringent regulatory standards and growing demand for precision-based healthcare manufacturing and validation processes.
Five Recent Developments
- Eurofins Scientific (2025): Expanded its biologics testing facility in the U.S., adding 30 000 sq ft of new lab space and boosting sample throughput by 25 %.
- Labcorp (2024): Launched a new centralized analytical platform integrating AI-driven data validation, cutting turnaround time by 18 % across global clinical test sites.
- SGS (2024): Opened a state-of-the-art GMP analytical lab in Singapore to serve APAC clients, increasing regional analytical testing capacity by 40 %.
- Charles River Laboratories (2023): Introduced a digital audit-trail system across its North American labs, improving regulatory traceability by 22 %.
- Wuxi Pharmatech (2023): Expanded its microbial testing services network to 10 new cities in China, supporting 15 % more clinical-trial sample loads than the previous year.
Report Coverage of Healthcare Analytical Testing Services Market
The Healthcare Analytical Testing Services Market Report provides comprehensive coverage of the global analytical testing landscape, including detailed segmentation by type, application, and region. The report examines more than 500 market participants, analyzing capacity, service portfolios, and outsourcing trends from 2020 to 2025. It outlines key drivers such as the 28 % increase in outsourcing contracts, regulatory compliance demands, and expansion of bioanalytical and stability testing capacities worldwide.
The study includes performance insights across North America (38.5 % share), Europe (28 %), Asia-Pacific (22 %), and Middle East & Africa (11.5 %), offering precise data on market share distribution, laboratory growth, and testing volume statistics. Additionally, it evaluates technological innovations, investment trends, and partnership structures shaping market evolution. The report further highlights competitive benchmarking of leading players—Eurofins, Labcorp, SGS, and Charles River—supported by quantitative metrics across testing demand, facility expansion rates, and regional penetration levels for strategic decision-making.
.svg)
